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The Relationship Between Blood Lead,
Blood Pressure, Stroke, and Heart Attacks
in Middle-Aged British Men
by S. J. Pocock,* A. G. Shaper,* D. Ashby,t H. T. Delves,+
and B. E. Claytont
The relationship between blood lead concentration and blood pressure is examined in a survey of
7371 men aged 40 to 59 from 24 British towns. After allowance for relevant confounding variables,
including town of residence and alcohol consumption, there exists a very weak but statistically
significant positive association between blood lead and both systolic and diastolic blood pressure.
These cross-sectional data indicate that an estimated mean increase of 1.45 mm Hg in systolic blood
pressure occurs for every doubling of blood lead concentration with a 95% confidence interval of
0.47 to 2.43 mm Hg.
After 6 years of follow-up, 316 of these men had major ischemic heart disease, and 66 had a
stroke. After allowance for the confounding effects ofcigarette smoking and town of residence there is
no evidence that blood lead is a risk factor for these cardiovascular events. However, as the blood
lead-blood pressure association is so weak, it is unlikely that any consequent association between
lead and cardiovascular disease could be demonstrated from prospective epidemiological studies.
An overview of data from this and other large epidemiological surveys provides reasonably
consistent evidence on lead and blood pressure. While NHANES II data on 2254 U.S. men indicate
a slighdy stronger association between blood lead and systolic blood pressure, data from two Welsh
studies on over 2000 men did not show a statistically significant association. However, the
overlapping confidence limits for all these studies suggest that there may be a weak positive
statistical association whereby systolic blood pressure is increased by about 1 mm Hg for every
doubling of blood lead concentration. Nevertheless, such statistical association cannot be taken as
establishing a causal effect of low-level lead exposure on blood pressure, particularly since there are
important confounders, e.g., alcohol consumption, which are much more strongly related to blood
pressure.
Introduction
The hypothesis that moderate elevations in blood
lead concentration are associated with increased blood
pressure in humans is supported by considerable
experimental evidence in laboratory animals (1,2).
Since direct experimental evidence in humans cannot
be obtained, the principal investigational approach in
humans has been with observational studies in repre-
sentative samples of either the general adult population
or occupationally exposed groups.
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This paper describes cross-sectional results from one
large survey, the British Regional Heart Study
(BRHS). Since our original publication on this topic
claiming a lack of association between blood lead and
blood pressure (3), studies of data from the United
States National Health and Nutrition Examination
Survey (NHANES II) have concluded that there is an
important association (4,5). Hence, it is opportune to re-
examine our data, paying careful attention to the role
of confounding factors such as town of residence and
alcohol consumption.
In addition, the BRHS is a prospective study, and the
men are being followed for fatal or nonfatal cardio-
vascular events since initial screening. Hence, new
results are presented concerning whether moderate
elevations in blood lead are related to risk of ischemic
heart disease (IHD) or stroke.POCOCKETAL.
It is unrealistic to expect any single epidemiological
study to provide definitive answers concerning blood
lead-blood pressure relationships. Therefore, this paper
also presents an overview of the collective evidence
from all the major surveys in this field and demon-
strates a greater consistency of evidence than might be
achieved from separate perusal of the findings and
conclusions from each individual study.
Methods
The BRHS examined 7735 men aged 40 to 59 who
were randomly selected from the age-sex registers of
representative general practices in 24 British towns.
Details of the selection of towns and general practices
and the methods of screening and data collection have
previously been reported (6). Each man's blood pres-
sure was measured twice in succession with the Lon-
don School of Hygiene sphygmomanometer, with the
subject seated and his arm supported on a cushion.
Diastolic blood pressure was recorded at disappearance
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of sounds (phase V). The mean oftwo readings ofblood
pressure was adjusted for observer variation within
each town to allow for any inconsistencies among the
three observers (7).
Blood samples for lead analysis were obtained from
7379 men (95%). Blood lead concentrations were ana-
lyzed at the University of Southampton with flame
microsampling atomic absorption spectroscopy. A strict
quality control protocol was maintained, and the
performance of the laboratory was continually moni-
tored by participation in national and international
quality assessment schemes for analysis of blood lead
concentration.
Alcohol consumption was recorded using questions
of frequency and quantity. A drink was defined as half
a pint of beer, one glass of wine, or a single shot of
spirits. For data analysis, eight drinking categories
were used: nondrinker, occasional drinker, weekend
drinker (1-2, 3-6, or > 6 drinks a day), and daily
drinker (1-2, 3-6, or > 6 drinks a day). For
illustration, in Figures 1 and 2 these are combined to
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FIGURE 1. Mean systolic and diastolic blood pressures for men categorized by blood lead concentration, body mass index, alcohol consumption, and
age.
160 -
E 150- E
a)
( 140-
(n
a) C)
-o 90-
0
.o
< 80- (9
a)
Systolic
D astolic
No. of men: 3033
55-59
1836 1896 1974 2021
24BLOOD LEADAND BLOOD PRESSURE INBRITISHMEN
form four drinking categories: nondrinker or
occasional drinker, light drinker (1-2 daily or on
weekends), moderate (3-6 daily or on weekends), and
heavy drinker ( > 6 daily or on weekends).
Cigarette smoking habits derived from a standard-
ized questionnaire were as follows: never smoked
cigarettes, ex-cigarette smoker, and current cigarette
smoker atfour levels (1-19, 20, 21-39, > 40 per day). Ex-
cigarette smokers who currently smoked a pipe/cigars
are included in ex-cigarette smokers. Those men who
had only ever smoked pipe/cigars are included in
never smoked cigarettes. For both current and ex-
smokers, the number of years a man had smoked cig-
arettes was also recorded, this variable (smoking years)
being a strong smoking-related predictor of IHD risk
(8).
All of the 7735 men who were initially examined
from 1978 to 1980 were scheduled to be followed up for
both morbidity and mortality for 8 years. So far, 99% of
the original cohort still alive and living in Great
Britain are being followed up. Details of the follow-up
procedures have been published (9). All cases of major
IHD and stroke occurring between screening and
August 1985 are included in this paper.
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Results
Personal Factors Related to Blood
Pressure and Blood Lead
Figure 1 shows a simple display of the univariate
association between blood lead and blood pressure in
the 7371 men for whom both were measured. There is
some suggestion of a rise in mean systolic pressure as
blood lead increases, but the correlation coefficient is
only 0.03. However, there are several personal charac-
teristics in middle-aged men that are known to be
associated with blood pressure. For example, Figure 1
also shows the trends in mean systolic and diastolic
pressure for these same men grouped according to
body mass index, age, and alcohol consumption.
Clearly, body mass index and age are important
determinants of individual blood pressure, but alcohol
consumption is also an important confounding vari-
able in view of its substantial association with blood
lead concentration (10,11) (Fig. 2), as well as with blood
pressure (6,12). Two other relevant personal factors are
cigarette smoking and social class. The former is
clearly associated with blood lead concentration (10,11)
(Fig. 2); the latter has weak associations with both
blood pressure and blood lead.
Geographic Difference
There are major geographic differences in both
mean systolic blood pressure and mean blood lead
concentration (Fig. 3). Although there is no evidence
of a statistical association for the between-town dif-
ferences in blood pressure and blood lead, it is still
relevant that town of residence should be taken into
account when studying this potential lead-blood pres-
sure relationship in individuals.
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FIGURE 2. Mean blood lead concentration for men categorized by their
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FIGURE 3. The town mean systolic blood pressure plotted against the
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24 British towns.
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Blood Pressure and Blood Lead
(Unadjusted)
Figure 4 provides a more detailed display of mean
systolic and diastolic blood pressure according to blood
lead concentration. For blood lead between 0.4 and 1.1
,umole/L, mean pressures are shown for each 0.1
imole/L interval of blood lead. Above 1.1 ,umole/L,
men are grouped into two categories, 1.2 to 1.3 ,umole/L
and 1.4 gmole/L or more, so as to preserve approx-
imately 300 men in each category. All the displayed 95%
confidence intervals overlap with one another, and
also the mean systolic and diastolic blood pressures in
the highest blood lead category show no elevation
above the average. Thus, detailed univariate analyses
show no encouragement for the hypothesis that blood
lead and blood pressure are positively associated.
Blood Pressure and Blood Lead
(Adjusted for Other Factors)
The situation appears to change once relevant per-
sonal factors are taken into account. An analysis of
covariance technique has been used to obtain adjusted
mean systolic and diastolic blood pressure for each
blood lead category, adjustment being for body mass
index, age, alcohol consumption (8 categories), ciga-
rette smoking (6 categories), social class (6 categories),
and town of residence (24 categories). The consequent
plots of adjusted mean systolic and diastolic blood pres-
sure by blood lead in Figure 5 show signs of a weak
positive association. Particularly, for the diastolic
pressure there is a steady increase in adjusted mean
from around 81 mm Hg for blood lead below 0.6
gmole/L to around 83.5 mm Hg for blood lead over 1.0
,umole/L.
Multiple Regression Analysis
This association can be further explored by multiple
regressions of systolic and diastolic blood pressure on
log(blood lead) and the covariatesjust mentioned. Table
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FIGURE 4. Mean systolic and diastolic blood pressures (and their 95%
confidence limits) for men categorized in intervals of0.1 pmole/L of
blood lead concentration. (The two highest blood lead groupings
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FIGuRE 5. Mean systolic and diastolic blood pressures by blood lead
concentration after adjustment for body mass index, alcohol
consumption, cigarette smoking, social class, and town ofresidence.
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1 shows the regression coefficients for log(blood lead)
for three different models: a) unadjusted for other
factors; b) adjusted for age, body mass index, alcohol,
smoking, and social class; and c) adjusted also for town
of residence. The log transform is used because blood
lead has a lognormal distribution, the regression fit is
slightly improved, and also the findings are then
more directly comparable with other studies. In the
unadjusted regression, systolic (but not diastolic) blood
pressure is significantly associated with log(blood
lead). Adjustment for personal characteristics, but not
town of residence, renders both the systolic and dias-
tolic regressions on log(blood lead) insignificant. This
is chiefly because alcohol consumption is an important
confounder, being positively related to both blood pres-
sure and blood lead. Introducing an extra adjustment
for town of residence makes both the systolic and dias-
tolic regressions highly statistically significant (p =
0.003 and 0.001, respectively). However, it should be
noted that these adjusted statistical associations are still
very weak, partial correlation coefficients being 0.04
and 0.05 for the systolic-blood lead and diastolic-blood
lead associations, respectively, so that statistical sig-
nificance is achieved only because of the large number
ofsubjects in the survey.
As a means of quantifying the magnitude of these
adjusted relationships, one can use the regression coef-
ficient and its standard error for log(blood lead) to
obtain the estimated increase in blood pressure for each
doubling of blood lead concentration. This is 1.45 mm
Hg for systolic pressure (95% confidence interval, 0.47-
2.43 mm Hg) and 1.25 mm Hg for diastolic pressure
(95% confidence interval, 0.65-1.85 mm Hg).
Separate Analyses Within Each Town
It is important to remember the geographic basis of
the BRHS whereby the sample of 7371 men analyzed
here come from 24 towns, approximately 300 men per
town. Table 2 shows the results of separate univariate
regression analyses ofblood pressure on log(blood lead)
for the men in each town. These findings demonstrate
that the weakness of the blood lead-blood pressure
Table 1. Regressions ofsystolic and diastolic blood pressure on
ln(blood lead) with and without adjustments for other personal
factors and town ofresidence.
Regression coefficient
for ln(blood lead) p-value
Systolic blood pressure
Unadjusted 1.684 0.009
Adjusted forbody mass 0.675 0.28
index, age, alcohol, smoking,
and social class
Adjusted also fortown 2.089 0.003
Diastolic blood pressure
Unadjusted 0.302 0.46
Adjusted forbody mass -0.063 0.87
index, age, alcohol, smoking,
and social class
Adjusted also for town 1.809 0.001
Table 2. Separate univariate regression analyses for the men in
each town.
Regression coefficient (SE)
Systolic blood Diastolic blood
Town pressure on ln(Pb) pressure on ln(Pb)
Newcastle 11.4 (4.3) 4.4 (2.9)
Burnley 10.6 (3.4) 7.2 (2.2)
Dewsbury 5.8 (3.5) 2.7 (2.4)
Wigan 5.6 (3.1) 2.6 (1.8)
Southport 5.6 (4.3) 3.8 (2.3)
Harrogate 5.5 (4.1) 4.8 (2.5)
MerthyrTydfil 5.5 (4.2) 3.2 (2.3)
Darlington 5.0 (3.5) - 3.0 (2.2)
Mansfield 5.0 (4.4) 6.1 (2.6)
Falkirk 4.2 (4.0) - 0.4 (2.8)
Shrewsbury 3.8 (4.3) 1.9 (2.6)
Grimsby 2.8 (2.9) 1.6 (1.7)
Guildford 2.5 (3.8) 2.5 (2.3)
Ipswich 2.0 (2.9) - 0.5 (1.9)
Scunthorpe 1.9 (2.8) 3.0 (1.7)
Ayr 1.6 (2.8) 0.7 (1.8)
Exeter 1.5 (3.0) - 0.4 (2.2)
Carlisle 1.3 (3.0) 1.8 (1.8)
Lowestoft 1.0 (3.9) - 2.2 (2.4)
Maidstone 0.9 (2.9) 1.2 (1.9)
Dunfermline 0.6 (3.5) - 0.2 (2.2)
Hartlepool - 1.4 (3.4) 0.8 (2.0)
Bedford -1.7 (4.5) 5.1 (2.8)
Gloucester -3.1 (4.4) 2.4 (2.8)
association is such that studies based on a few hundred
men contain too much random variation and cannot
be expected to produce consistent, precise findings. For
instance, the within-town regressions of systolic blood
pressure on log(blood lead) produced large significant
coefficients in Newcastle and Burnley, while at the
other extreme, there were three towns, Hartlepool, Bed-
ford, and Gloucester, with small negative coefficients.
In fact, from inspection of the standard errors of each
such coefficient, one can see that such differences are
largely attributable to random variation, and they are
all in broad agreement with a true average regression
coefficient of 3.0. Adjustment for alcohol consumption
as a confounder reduces this coefficient to 2.0, which is
the overall pooled estimate already derived in the
multiple regression in Table 1.
Blood Lead and Cardiovascular Events
Table 3 shows the mean blood lead concentration for
316 men who have experienced major ischemic heart
disease since initial screening compared with the 7063
other men. The mean blood level concentration is
significantly higher in these IHD cases (p = 0.01), but
this is without taking account of important con-
founding variables. In particular, cigarette smoking is
an established risk factor for IHD, which also elevates
blood lead concentrations (Fig. 2). The towns with
higher IH,D mortality tend to have slightly higher
blood lead concentrations, perhaps because blood lead
levels are higher in soft water areas (13), which are
known to have higher IHD mortality (14,15). There-
fore, analysis of covariance has been used to obtain an
27POCOCKETAL.
Table 3. Mean blood lead concentrations for men with
subsequent ischemic heart disease and stroke compared
with other men, with and without adjustment for age,
smoldng years, and town ofresidence.
IHD Other Stroke Other
cases men cases men
No. ofmen 316 7063 66 7313
Mean blood lead, limole/L 0.786 0.735 0.808 0.737
Difference in means ± SE 0.051 ±0.019 0.071 ±0.049
Difference in means ± SE 0.014 ±0.015 0.033 ±0.033
after adjustmentfor age,
smoking years, and town
adjusted difference in mean blood lead between IHD
cases and other men adjustment being for age, number
of years smoking cigarettes, and town of residence (24
categories). This adjustment has reduced the mean
excess in blood lead among IHD cases from 0.051
gmole/L to 0.014 ,umole/L, which is no longer sig-
nificantly different from zero. Table 3 also shows sim-
ilar results for the 66 cases of stroke compared with
other men.
An alternative method of studying blood lead as a
possible IHD risk factor is to estimate the relative odds
ofbecoming an IHD case for different intervals ofblood
lead. Using the 1986 men with blood lead concentra-
tion under 0.6 gmole/L as a reference group, Figure 6
shows that the odds (or risk) of IHD is somewhat
greater at higher blood lead concentrations, partic-
ularly at 1.2 imole/L or more. However, use of logistic
regression analysis to obtain relative odds adjusted for
age, smoking years, and town of residence shows no
evidence ofan excess risk of IHD at these higher blood
lead concentrations.
Overview of Other Large Studies of
Blood Lead-Blood Pressure
Relationships
In any specific field of epidemiological research, no
single observational study can be relied upon to
2.0
provide a definitive answer, particularly when the
relationship under study is quite weak and in the
presence of strong potential confounders. In this pre-
liminary attempt to present the collective evidence
from ours and other studies of the lead-blood pressure
relationship, attention is confined to the larger studies
for which appropriate regressions of systolic blood
pressure on blood lead are available. As already illus-
trated in Table 2, studies on a few hundred subjects can
produce highly variable estimates of the lead-blood
pressure association. Also, the available data in such
smaller studies are liable to suffer from publication
bias, whereby the more positive small studies are more
likely to be published. Studies ofunder 500 subjects will
therefore not be mentioned further. All results pre-
sented referto males only.
For each study we present the estimated change in
mean systolic blood pressure for a doubling of blood
lead. This is obtained from the principal regression
analysis that the authors selected. These findings are
displayed in Figure 7 with the 95% confidence limits.
For the BRHS these results are directly obtained from
the regression coefficient for log(blood lead) after
adjustment for town of residence and other covariates
(Table 1). For NHANES II, the results are similarly
determined from data on 2254 males aged 20 to 74 after
adjustment for site and several other biochemical,
dietary, and personal factors (16). For the two Welsh
studies on 1164 and 865 men, respectively, linear
regression was used, adjusting for age only, and hence
we have plotted the mean change in systolic blood
pressure for one specific doubling of blood lead con-
centration (8 to 16 ig/dL) in the middle of their blood
lead distributions.
The two Welsh studies show no significant asso-
ciation, whereas NHANES II data show an estimated
increase of 2.24 mm Hg in systolic blood pressure for a
doubling of blood lead concentration, which is larger
than in the BRHS. However, the overlapping con-
fidence intervals indicate that these findings are not
consistent, and all studies are compatible with a pos-
sible increase in systolic blood pressure of approxi-
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mately 1 to 2 mm Hg for a doubling of blood lead
concentration. It should also be noted that two other
studies in Canada (18) and Denmark (19) on 2193 and
950 subjects, respectively, have found no significant
association, but we do not have their regression results
available as yet. This would imply that the lower figure
of 1 mm Hg systolic increase per doubling ofblood lead
is more plausible.
Discussion
Blood Lead and Blood Pressure in BRHS
and NHANES II
Earlier publications on lead and blood pressure from
the BRHS (3) and NHANES II (5) have appeared to
reach widely divergent conclusions; this journal issue
provides an opportunity for reassessment of these two
studies using comparable statistical approaches. While
NHANES II continues to show a markedly stronger
relationship in the selected subgroup of white males
aged 40 to 59, this discrepancy is largely removed once
one compares regression results for all adult males in
the two studies.
Alcohol Consumption
The choice of other covariates as potential con-
founders has had an important effect on the two
studies' results. In the BRHS, alcohol consumption is
of particular importance, being positively related to
blood pressure and blood lead. It should be noted that
the alcohol-blood pressure relation in the BRHS is
virtually unaffected by adjustment for blood lead levels,
indicating that alcohol's effect on blood pressure is not
produced by any lead-related mechanism, such as the
lead content of alcoholic drinks. This supports the view
that alcohol is a genuine confounder. It is impossible to
obtain a fully comprehensive measure of alcohol con-
sumption by simple questionnaire (e.g., in the BRHS,
all men drinking over six units per day are grouped
together, and this may mean that the alcohol-related
component in the univariate lead-blood pressure rela-
tionship is not completely allowed for in the multiple
regression. This same point relates to NHANES II, as
their information on alcohol was not very detailed.
Allowance for Geographic Differences
Both NHANES II and the BRHS are cross-sectional
surveys among individuals from many geographical
areas. They have a two-stage design, the first being
nonrandom selection of geographic locations and the
second being random selection of individuals from a
defined sampling frame in each location. It has now
become recognized that particularly when studying a
weak statistical association such as lead and blood
pressure it is important to take account of this
geographical component to the study. In the BRHS,
failure to adjust for town of residence actually under-
played the significance of the statistical association.
However, in NHANES II, the strength of association
was reduced after adjustment for site, perhaps because
sites with higher mean blood pressure tended to have
higher mean blood lead levels, possibly as a conse-
quence ofthe time trends in both blood lead and percent
urban dwellers at the sampling sites.
Overview of Major Studies
In our overview of the major studies in this field
(Fig. 7) we have aimed for an objective quantification
of the magnitudes of association between blood lead
and systolic blood pressure. Subjective assessment of
such data tend to classify studies as either significant
or nonsignificant, but this dichotomous attitude
toward assessment of scientific hypotheses is over-
simplistic and counter-productive. It fails to take
account of the limited power that individual studies
have to detect weak relationships. We have been able to
demonstrate some consistency between the larger
studies suggestive of a very weak positive association,
but it is also important to realize the limitations of this
approach. Specifically, the different studies have
adopted very different strategies toward the selection of
other covariates to be used in the regression models.
For instance, the BRHS selected a limited set ofpersonal
covariates related to blood pressure and blood lead,
whereas NHANES II did an extensive selection process
across a wide range of personal, biochemical, and
dietary data. The Welsh analyses undertaken thus far
have only adjusted for age. Greater consistency in the
handling of confounders would provide more reas-
surance as to the validity of our overview approach.
However, a previous NHANES II report (5) has
claimed a stability of blood lead-blood pressure asso-
ciation for several different approaches to selecting
covariates in their data. Therefore, it seems plausible to
argue that the overall assessment of the data on all
available studies is not likely to be changed substan-
tially by further statistical analysis.
Interpretation of the Statistical
Association
The crucial issue is whether this evidence of a weak
statistical association is evidence ofacausal effect oflow-
level lead exposure. Here we need to accept the limita-
tions of observational epidemiology, which cannot
provide definitive evidence of a causal link. Further-
more, the strength of statistical evidence here is not
substantial. The difficulty of completely allowing for
important confounders, e.g., alcohol consumption and
the fact that only two of the six largest studies have
achieved statistical significance, would suggest that
this is one area where the epidemiological approach
cannot provide a clear answer. It would be premature to
conclude that these statistical findings are of practical
relevance to public health.
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Blood Lead, Heart Attacks, and Strokes
We are not aware of any previous prospective
epidemiological studies of coronary heart disease and
stroke that have included blood lead as a potential risk
factor. However, it has been hypothesized that trace
metals such as lead may explain the relationship be-
tween soft water and cardiovascular disease and also
that clinical lead poisoning includes signs suggestive
of a toxic effect on the heart (20). Also, Pirkle et al. (5)
have extrapolated from their blood lead-blood pressure
relationship in NHANES II data to argue that there
could be substantial reductions in the numbers of
strokes and heart attacks as a result of the decline in
blood lead levels in the United States since the mid-
1970s.
In this paper we have shown that mean blood lead
levels are somewhat higher in individuals who sub-
sequently have a heart attack or stroke. However, after
allowance for cigarette smoking and town of residence,
this association is no longer statistically significant.
One cannot automatically infer that low-level lead
exposure has no effect on risk ofstroke and heart attack,
but the evidence clearly indicates that lead is not a
major contributor to risk of cardiovascular disease. It is
still worth considering whether a possible blood lead-
blood pressure relationship could have implications
for risk of major cardiovascular events, but the
estimates provided by earlier research (5) would seem
extravagant, as the collective evidence suggests a much
weaker blood lead-blood pressure relationship than
they have previously claimed. Thus, there remains the
possibility that an extremely small proportion (less
than 1%) ofstrokes and heart attacks could be prevented
by substantial reductions in mean blood lead concen-
tration in the general population. This inference
depends on a causal interpretation of statistical asso-
ciations, but we have no direct evidence that changes
in population lead levels would actually affect the
population's blood pressure, and there even remains
controversy over whether lowering of blood pressure
reduces the risk ofheart attacks (21). In conclusion, we
see no convincing epidemiological evidence at present
to support the claim that moderate elevations in body
lead burden are of relevance to the risk of cardio-
vascular disease.
The British Regional Heart Study is a British Heart Foundation
Research Group and is also supported by the Medical Research
Council, Department of Health and Social Security, the Scottish
Endowment Research Trust and the Chest Heart and Stroke
Association. Estimation ofblood lead concentrations was supported by
the Department ofHealth and Social Security.
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